Tauopathies
·MeSH: Tauopathies
Prevalence
50.0 / 100K
Incidence
5.0 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| AL064 | Alector, Inc. (ALEC) |
Frequently asked questions
How many drugs are in development for Tauopathies?
BioSniper tracks 1 drug in development for Tauopathies across 1 company.
How many clinical trials target Tauopathies?
There are 3 clinical trials targeting Tauopathies tracked by BioSniper.
What is the prevalence of Tauopathies?
The estimated prevalence of Tauopathies is approximately 50.0 per 100,000 population.
Deep-dive into Tauopathies
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis